Active salvage chemotherapy versus best supportive care for patients with recurrent or metastatic squamous cell carcinoma of the esophagus refractory or intolerable to fluorouracil, platinum, and taxane

被引：0
|
作者：
Motoo Nomura
Satoru Iwasa
Takahiro Tsushima
Ken Kato
Hirofumi Yasui
Narikazu Boku
Manabu Muto
Kei Muro
机构：
[1] Aichi Cancer Center Hospital,Department of Clinical Oncology
[2] Kyoto University Graduate School of Medicine,Department of Therapeutic Oncology
[3] National Cancer Center Hospital,Division of Gastrointestinal Medical Oncology
[4] Shizuoka Cancer Center,Division of Gastrointestinal Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 78卷
关键词：
Esophageal cancer; Metastasis; Best supportive care; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1209 / 1216
页数：7
相关论文
共 50 条
  • [41] Maintenance gemcitabine versus best supportive care following platinum-paclitaxel chemotherapy for patients with advanced nonsmall cell lung cancer
    Satyanarayan
    Beniwal, Surender
    Kapoor, Akhil
    Mittal, Aditi
    Jakhar, Shankar Lal
    Sharma, Neeti
    Kumar, Harvindra Singh
    Khichar, Satyendra
    CLINICAL CANCER INVESTIGATION JOURNAL, 2016, 5 (03): : 236 - 239
  • [42] A phase II trial of modified weekly irinotecan and cisplatin for chemotherapy-naive patients with metastatic or recurrent squamous cell carcinoma of the esophagus
    Lee, Dae Ho
    Kim, Heung Tae
    Han, Ji-Youn
    Lee, Sung Young
    Yoon, Sung Jin
    Kim, Hyae Young
    Lee, Jin Soo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (01) : 83 - 88
  • [43] Response to salvage chemotherapy with paclitaxel plus /cetuximab after progression on immune checkpoint inhibitors in platinum-refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) patients (CeTax study)
    Gomez, R. G. Herrera
    Saleh, K.
    Auclin, E.
    Vinches, M.
    Gervais, C.
    Espeli, V. G.
    Rothschild, S. I.
    Even, C.
    Cristina, V.
    ANNALS OF ONCOLOGY, 2023, 34 : S592 - S592
  • [44] Nimotuzumab plus platinum-based chemotherapy versus platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
    Zhu, Yunshu
    Yang, Sheng
    Zhou, Shengyu
    Yang, Jianliang
    Qin, Yan
    Gui, Lin
    Shi, Yuankai
    He, Xiaohui
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [45] Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC)
    Sun, Lova
    Cohen, Roger B.
    Colevas, A. Dimitrios
    ORAL ONCOLOGY, 2024, 158
  • [46] Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN): Results of a phase II study.
    Trigo, J
    Hitt, R
    Koralewski, P
    Diaz-Rubio, E
    Rolland, F
    Knecht, R
    Amellal, N
    Bessa, EH
    Baselga, J
    Vermorken, JB
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 488S - 488S
  • [47] Timing of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy
    Motoo Nomura
    Taisuke Hosokai
    Masashi Tamaoki
    Akira Yokoyama
    Shigemi Matsumoto
    Manabu Muto
    Esophagus, 2023, 20 : 722 - 731
  • [48] Timing of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy
    Nomura, Motoo
    Hosokai, Taisuke
    Tamaoki, Masashi
    Yokoyama, Akira
    Matsumoto, Shigemi
    Muto, Manabu
    ESOPHAGUS, 2023, 20 (04) : 722 - 731
  • [49] Apatinib plus radiotherapy or not in chemotherapy-refractory recurrent or metastatic oral squamous cell carcinoma: A pilot study
    Wu, Hui
    Lu, Xiaoxu
    Xu, Jing
    Sun, Xueming
    Wang, Shujuan
    Du, Wei
    Liu, ShanTing
    Li, DingJie
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma
    Park, Byeong-Bae
    Im, Young-Hyuck
    Hwang, In Gyu
    Lee, Sang Cheol
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Lim, Yeong
    Kang, Won Ki
    Park, Keunchil
    INVESTIGATIONAL NEW DRUGS, 2008, 26 (04) : 387 - 392
12345